- Home
- NVO vs BABA Comparison
NVO vs BABA Comparison
Compare NVO & BABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVO
- BABA
- Stock Information
- Founded
- NVO 1923
- BABA 1999
- Country
- NVO Denmark
- BABA China
- Employees
- NVO N/A
- BABA N/A
- Industry
- NVO Biotechnology: Biological Products (No Diagnostic Substances)
- BABA Business Services
- Sector
- NVO Health Care
- BABA Consumer Discretionary
- Exchange
- NVO Nasdaq
- BABA Nasdaq
- Market Cap
- NVO 278.0B
- BABA 253.6B
- IPO Year
- NVO N/A
- BABA 2014
- Fundamental
- Price
- NVO $65.73
- BABA $125.25
- Analyst Decision
- NVO Strong Buy
- BABA Strong Buy
- Analyst Count
- NVO 4
- BABA 14
- Target Price
- NVO $128.00
- BABA $154.15
- AVG Volume (30 Days)
- NVO 11.2M
- BABA 16.6M
- Earning Date
- NVO 05-07-2025
- BABA 05-15-2025
- Dividend Yield
- NVO 2.45%
- BABA 0.78%
- EPS Growth
- NVO 17.93
- BABA 27.15
- EPS
- NVO 3.40
- BABA 6.75
- Revenue
- NVO $43,922,211,349.00
- BABA $134,505,212,800.00
- Revenue This Year
- NVO $20.22
- BABA $8.32
- Revenue Next Year
- NVO $16.10
- BABA $6.95
- P/E Ratio
- NVO $19.32
- BABA $18.60
- Revenue Growth
- NVO 24.11
- BABA 5.85
- 52 Week Low
- NVO $57.00
- BABA $71.80
- 52 Week High
- NVO $148.15
- BABA $148.43
- Technical
- Relative Strength Index (RSI)
- NVO 48.22
- BABA 55.73
- Support Level
- NVO $64.40
- BABA $122.91
- Resistance Level
- NVO $69.67
- BABA $129.73
- Average True Range (ATR)
- NVO 1.74
- BABA 2.66
- MACD
- NVO 0.85
- BABA 1.44
- Stochastic Oscillator
- NVO 62.20
- BABA 73.21
About NVO Novo Nordisk A/S
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About BABA Alibaba Group Holding Limited
Alibaba is the world's largest online and mobile commerce company as measured by gross merchandise volume. It operates China's online marketplaces, including Taobao (consumer-to-consumer) and Tmall (business-to-consumer). The China commerce retail division is the most valuable cash flow-generating business at Alibaba. Additional revenue sources include China commerce wholesale, international commerce retail/wholesale, local consumer services, cloud computing, digital media and entertainment platforms, Cainiao logistics services, and innovation initiatives/other.